Related Experiment Video
Updated: Jul 30, 2026

12:06
Confocal Imaging of Single Mitochondrial Superoxide Flashes in Intact Heart or In Vivo
Published on: November 6, 2013
Heart failure, oxidative stress, and ion channel modulation
Gaurav Choudhary1, Samuel C Dudley
1Department of Medicine, Division of Cardiology, Emory University, Atlanta, GA, USA.
Congestive Heart Failure (Greenwich, Conn.)
|June 5, 2002
Summary
Cellular redox balance, involving reactive oxygen species (ROS) and nitric oxide, is crucial in heart failure. Imbalances in these molecules impair calcium handling and contractile function.
Area of Science:
- Cardiovascular Physiology
- Cellular Redox Biology
Background:
- The cellular redox state, influenced by reactive oxygen species (ROS) and nitric oxide, plays a critical role in heart failure pathogenesis.
- Dysregulation of ROS and nitric oxide levels is observed in heart failure, impacting cellular functions.
Purpose of the Study:
- To investigate the intricate relationship between cellular redox balance (ROS and nitric oxide) and calcium-handling proteins in the context of heart failure.
- To elucidate how altered redox states affect excitation-contraction coupling and contractile dysfunction.
Main Methods:
- Analysis of cellular redox state, including reactive oxygen species (ROS) and nitric oxide levels.
- Assessment of calcium-handling protein expression and function.
- Evaluation of excitation-contraction coupling and myocardial contractility.
Main Results:
- Elevated levels of both ROS and nitric oxide are prevalent in heart failure.
- Significant impairments in the quantity and functionality of calcium-handling proteins were observed.
- Oxidative and nitrosative modifications of cysteine residues in these proteins contribute to their dysfunction.
Conclusions:
- The balance of ROS and nitric oxide is vital for maintaining normal cardiac function and is disrupted in heart failure.
- Impaired calcium handling due to redox-induced alterations in calcium-handling proteins contributes significantly to contractile dysfunction in heart failure.
- While initial increases in nitric oxide may be adaptive, excessive levels of ROS and nitric oxide are detrimental, leading to peroxynitrite formation and further cellular damage.
Related Concept Videos
Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

